Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2012
11/08/2012US20120282282 Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
11/08/2012US20120282281 Agents that Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR)
11/08/2012US20120282280 Bi-specific digoxigenin binding antibodies
11/08/2012US20120282278 Anti p2x7 receptor antibodies and fragments thereof
11/08/2012US20120282272 Novel target in the treatment of cytokine release syndrome
11/08/2012US20120282271 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
11/08/2012US20120282270 Formulation of human antibodies for treating tnf-alpha associated disorders
11/08/2012US20120282269 Anti-IL-23 Antibodies
11/08/2012US20120282267 Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain
11/08/2012US20120282266 Anti-neoplastic uses of artemin antagonists
11/08/2012US20120282261 Deuterated analogs of (4S)-4-Ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3', 4':6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof
11/08/2012US20120282259 Mutant smoothened and methods of using the same
11/08/2012US20120282258 Crlf2 in precursor b-cell acute lymphoblastic leukemia
11/08/2012US20120282257 Single-chain variable fragment (scfv) able to recognize and bind cd99 human protein
11/08/2012US20120282256 Chimeric receptors with 4-1bb stimulatory signaling domain
11/08/2012US20120282245 Biomarkers and assays for the treatment of cancer
11/08/2012US20120282230 Methods and compositions for diagnosis and treatment of genetic and retinal disease
11/08/2012US20120282225 Method and composition for creating conditional lethality for virus mutants and for eliminating the viability of an eukaryotic cell
11/08/2012US20120282221 Bromo-phenyl substituted thiazolyl dihydropyrimidines
11/08/2012US20120282216 Composition and Method for Treating Cancer
11/08/2012US20120282215 Vaccination of Cancer Patients
11/08/2012US20120282196 Smoothened polypeptides and methods of use
11/08/2012US20120282185 Particles for the treatment of cancer in combination with radiotherapy
11/08/2012US20120282183 Prognostic,. screening and treatment methods and agents for treatment of metastasis and inflammation using 5t4 oncofoetal glycoprotein
11/08/2012US20120282180 Compounds with Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof
11/08/2012US20120282179 Methods of Using C-Met Modulators
11/08/2012US20120282175 Methods for Increasing Efficacy of FOLR1 Cancer Therapy
11/08/2012US20120282174 Synergistic Anti-CD47 Therapy for Hematologic Cancers
11/08/2012US20120282173 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
11/08/2012US20120282172 Targeted delivery to human diseases and disorders
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012US20120282168 Methods of sensitizing cancer to therapy-induced cytotoxicity
11/08/2012US20120282167 Method for predicting the sensitivity of a tumor to an epigenetic treatment
11/08/2012CA2838041A1 Methods for handling biological drugs containing living cells
11/08/2012CA2835109A1 Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals
11/08/2012CA2835015A1 Radiolabeled amino acids for diagnostic imaging
11/08/2012CA2834850A1 Methods for treating prostate cancer
11/08/2012CA2834778A1 Method of treating cancer and bone cancer pain
11/08/2012CA2834776A1 Vascular disruption agents and uses thereof
11/08/2012CA2834746A1 Novel compounds and compositions for the inhibition of nampt
11/08/2012CA2834696A1 Csf-1r inhibitors for treatment of brain tumors
11/08/2012CA2834695A1 Avian-based treatment
11/08/2012CA2834422A1 Method for utilizing extraction residue of yeast extract
11/08/2012CA2834414A1 Multiple myeloma treatment
11/08/2012CA2833935A1 Novel compounds as modulators of protein kinases
11/08/2012CA2833780A1 Prenylated hydroxystilbenes
11/08/2012CA2825163A1 Compositions for regulating iron homeostasis and methods of using same
11/07/2012EP2520652A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associates genes
11/07/2012EP2520651A2 Sirna for inhibiting c-met expression and an anti-cancer composition comprising the same
11/07/2012EP2520590A2 Cross-species-specific binding domain
11/07/2012EP2520589A1 Anti-cd27 antibody
11/07/2012EP2520580A1 Halogenated dideoxy saccharide derivatives, preparation method and use thereof
11/07/2012EP2520575A1 1,3,4-oxadiazole-2-carboxamide compound
11/07/2012EP2520568A1 Spirocyclic nitriles as inhibitors of protease
11/07/2012EP2520292A1 Use of spirangiens for the treatment or prevention of IL-8 or IL-6 mediated disorders
11/07/2012EP2520287A1 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
11/07/2012EP2520281A2 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
11/07/2012EP2519634A2 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
11/07/2012EP2519544A1 Polypeptide heterodimers and uses thereof
11/07/2012EP2519543A1 Heterodimer binding proteins and uses thereof
11/07/2012EP2519542A1 Anti-cdh3 antibodies and uses thereof
11/07/2012EP2519541A1 Ron binding constructs and methods of use thereof
11/07/2012EP2519526A1 Tricyclic compounds for use as kinase inhibitors
11/07/2012EP2519525A2 Substituted pyrrolo-aminopyrimidine compounds
11/07/2012EP2519524A1 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
11/07/2012EP2519522A2 Substituted imidazopyridinyl-aminopyridine compounds
11/07/2012EP2519519A2 Substituted naphthalenyl-pyrimidine compounds
11/07/2012EP2519518A2 Imatinib dichloroacetate and anti-cancer agent comprising the same
11/07/2012EP2519517A2 Type ii raf kinase inhibitors
11/07/2012EP2519508A2 Metalloenzyme inhibitor compounds
11/07/2012EP2519263A1 Lipopeptide- and lipoprotein-conjugates and its use
11/07/2012EP2519250A1 Interferon analogs
11/07/2012EP2519236A2 MOLECULES RELATED hERG Ion CHANNELS AND THE USE THEREOF
11/07/2012EP2519102A2 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/07/2012EP2213737B1 Double-stranded oligonucleotides
11/07/2012CN1871240B Pyrrolopyrimidine thion derivatives
11/07/2012CN1744901B Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis
11/07/2012CN102770561A Tissue-based micro-RNA methods for diagnosis of different subtypes of lung cancer
11/07/2012CN102770560A Plasma-based micro-RNA biomarkers and methods for early detection of colorectal cancer
11/07/2012CN102770456A Multispecific antibodies, antibody analogs, compositions, and methods
11/07/2012CN102770453A Anti-FLT3 antibodies and methods of using the same
11/07/2012CN102770429A Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
11/07/2012CN102770426A Compounds and compositions as protein kinase inhibitors
11/07/2012CN102770415A Polycyclic compounds as lysophosphatidic acid receptor antagonists
11/07/2012CN102770412A (Methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses
11/07/2012CN102770182A Substituted isoquinolinones and quinazolinones
11/07/2012CN102770137A Tumour treatment agents and method
11/07/2012CN102770131A Novel antitumoral use of cabazitaxel
11/07/2012CN102766634A Single-stranded deoxyribonucleic acid (ssDNA) aptamer targeting human highly metastatic hepatoma carcinoma cell and application thereof
11/07/2012CN102766632A Golgi apparatus membrane protein GP73 nucleic acid aptamer, as well as preparation method and application thereof
11/07/2012CN102766596A Novel regulatory T cells and uses thereof
11/07/2012CN102766262A Preparation method for difunctional nanoparticle carrier and preparation method for difunctional nanoparticle preparation
11/07/2012CN102766258A Resveratrol hydrophilic conjugate, its preparation method and application
11/07/2012CN102766222A P-containing modified chitosan lyotropic liquid crystal and preparation method thereof
11/07/2012CN102766215A Polypeptide with function of synergic targeting treatment of nasopharyngeal carcinoma, nanoparticle carrying the polypeptide and application thereof
11/07/2012CN102766210A Human CTLA-4 antibodies and their uses
11/07/2012CN102766186A Preparation method and application of ecdysone-rich plant standardized extract
11/07/2012CN102766184A Protopanoxadiol peroxide derivatives as well as preparation method and application thereof
11/07/2012CN102766180A Purification method for two active monomer compounds in saxifrage and application of product of the same
11/07/2012CN102766142A Lactam compounds useful as protein kinase inhibitors
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 2211